Antibiotic Management for Perforated Gallbladder
For a perforated gallbladder, initiate broad-spectrum intravenous antibiotics immediately and continue for 4 days post-operatively in immunocompetent patients with adequate source control, or up to 7 days in critically ill or immunocompromised patients.
Initial Antibiotic Selection
For Immunocompetent, Non-Critically Ill Patients
Amoxicillin-clavulanate 2g/0.2g IV every 8 hours is the preferred first-line agent for perforated gallbladder (complicated cholecystitis) when adequate source control is achieved. 1
Alternative regimens include:
- Piperacillin-tazobactam 3.375g IV every 6 hours 1
- Ertapenem 1g IV every 24 hours 1
- Ceftriaxone 1-2g IV every 12-24 hours PLUS metronidazole 500mg IV every 8-12 hours 1
- Moxifloxacin 400mg IV every 24 hours (if fluoroquinolone resistance is <10-20% locally) 1
For Critically Ill or Immunocompromised Patients
Piperacillin-tazobactam at higher dosing (6g/0.75g loading dose, then 4g/0.5g every 6 hours or 16g/2g continuous infusion) is recommended for critically ill patients with perforated gallbladder. 1
For beta-lactam allergies in this population:
- Eravacycline 1mg/kg IV every 12 hours 1
- Tigecycline 100mg loading dose, then 50mg IV every 12 hours 1
For Healthcare-Associated Infection or ESBL Risk
If there is inadequate/delayed source control or high risk of ESBL-producing organisms, use ertapenem 1g IV every 24 hours or a carbapenem (meropenem 1g every 8 hours, imipenem 500mg every 6 hours). 1
Duration of Therapy
The duration of antibiotic therapy depends critically on patient characteristics and adequacy of source control:
- 4 days post-operatively for immunocompetent, non-critically ill patients with adequate source control 1
- Up to 7 days for immunocompromised or critically ill patients, guided by clinical response and inflammatory markers 1
- Patients with ongoing signs of infection beyond 7 days warrant diagnostic re-evaluation 1
Critical Considerations for Source Control
Adequate source control is paramount—antibiotics alone are insufficient for perforated gallbladder. The primary intervention should be:
- Laparoscopic or open cholecystectomy 1
- Cholecystostomy for patients unfit for surgery (though inferior to cholecystectomy in critically ill patients) 1
- Percutaneous drainage may serve as a bridge to definitive intervention 1
Special Scenario: Iatrogenic Perforation During Laparoscopic Cholecystectomy
For iatrogenic gallbladder perforation during elective laparoscopic cholecystectomy, a single prophylactic antibiotic dose is sufficient—extended antibiotic courses do not reduce infectious complications. 2, 3, 4
This applies when:
- The abdominal cavity is thoroughly irrigated 4
- Spilled stones are retrieved whenever possible 4
- The patient is not diabetic, <60 years old, ASA class <3, and operative time <70 minutes 3
For high-risk patients (diabetes, age >60, ASA ≥3, or operative time >70 minutes), consider extending antibiotics beyond the single prophylactic dose. 3
Microbiological Considerations
Obtain intraoperative cultures from the infection site, particularly in:
- Healthcare-associated infections 1
- Patients with prior antibiotic exposure 1
- Critically ill or immunocompromised patients 1
At least 1mL of fluid or tissue should be collected and transported appropriately for aerobic and anaerobic cultures. 1 Susceptibility testing should be performed for Pseudomonas, Proteus, Acinetobacter, Staphylococcus aureus, and predominant Enterobacteriaceae. 1
Common Pitfalls to Avoid
- Do not continue antibiotics indefinitely without reassessing source control adequacy—persistent infection beyond 7 days indicates need for imaging/intervention, not just more antibiotics 1
- Do not use fluoroquinolones empirically without knowing local resistance patterns—E. coli resistance to fluoroquinolones is increasing 1
- Do not omit anaerobic coverage for biliary infections—metronidazole or a beta-lactam/beta-lactamase inhibitor is essential 1